DEVELOPMENT
DEVELOPMENT
TissueGen is advancing toward clinical development a pipeline of novel, extended release
TissueGen is advancing toward clinical development a pipeline of novel, extended release
formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases.
formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases.
MEDIA
PUBLICATIONS AND AWARDS
NEWS
August 2, 2018 By SARAH FAULKNER
April 18-19, 2018 By INNOVATION IN TEXTILES
February 22, 2018 By MED-TECH INNOVATION
May 18, 2017 By GLOBAL NEWS WIRE
October 3, 2017 By ANNA BUTLER
August 22, 2017 By DALLAS BUSINESS JOURNAL
June 9, 2017 By CHRIS NEWMARKER
MAY 19, 2017 By DR. KEVIN NELSON, FOUNDER AND CSO
March 29, 2017 By NATURE.COM
June 7, 2016, 2018 By ABIGAIL ESPOSITO
November 28, 2016 By DR. KEVIN NELSON, FOUNDER AND CSO OF TISSUEGEN INC.
March 30, 2016 By TODAY'S MEDICAL DEVELOPMENTS
AUGUST 8, 2016 By TECHNICAL TEXTILES
September 5, 2016 By ANNA BUTLER
April 18-19, 2018 By SARAH FAULKNER
2017 By MEDTECH BREAKTHROUGH AWARDS
February 27, 2017 By GLOBALNEWSWIRE